ePoster

DNA DAMAGE REPAIR DEFECTS IN AMYOTROPHIC LATERAL SCLEROSIS MOTOR NEURONS

Joris Van Lindtand 1 co-author

VIB-KU Leuven Center for Neuroscience

FENS Forum 2026 (2026)
Barcelona, Spain
Board PS05-09AM-245

Presentation

Date TBA

Board: PS05-09AM-245

Poster preview

DNA DAMAGE REPAIR DEFECTS IN AMYOTROPHIC LATERAL SCLEROSIS MOTOR NEURONS poster preview

Event Information

Poster Board

PS05-09AM-245

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder marked by the progressive loss of motor neurons, ultimately leading to paralysis and death. Emerging evidence suggests that accumulated defects in DNA damage repair contribute to motor neuron degeneration. However, the mechanisms linking dysregulated DNA repair to neurodegeneration—and whether these defects are a cause or consequence of disease—remain unclear.
To investigate DNA damage repair deficits, we employed iPSC-derived motor neurons from patients harboring C9ORF72 repeat expansions, the most common genetic cause of ALS, alongside their isogenic controls. DNA damage response was assessed using γ-H2AX, a well-known DNA damage response marker. Under basal conditions, ALS motor neurons displayed no difference in DNA damage response activation compared to controls. Remarkably, following DNA damage induced by inhibition of DNA topoisomerase I, ALS motor neurons exhibited impaired activation of the DNA damage response pathway. Furthermore, topoisomerase I inhibition disrupted additional neuronal phenotypes, including axonal transport and neurite outgrowth, underscoring the link between active DNA repair and motor neuron health.
In summary, our findings reveal a dysregulated DNA damage response in C9ORF72 ALS motor neurons and highlight its broader impact on neuronal function, offering new insights into mechanisms driving motor neuron vulnerability in ALS.

Recommended posters

CORTICAL NEURONS ARE NEURODEVELOPMENTALLY PRIMED TO DYSFUNCTION AND DEGENERATION IN AMYOTROPHIC LATERAL SCLEROSIS MOUSE MODELS

Marina Hernan Godoy, Aurélien Diebold, Geoffrey Stuart-Lopez, Charlotte Gorin, Verónique Devignot, Sylvie Grosch, Stéphane Dieterle, Pascal Kessler, Nathalie Brouard, Stéphanie Le Gras, Virginie Andry, Yannick Goumon, Caroline Rouaux

MOLECULAR PROFILING OF MICROGLIA-ASTROCYTE CROSSTALK IN C9ORF72 ALS/FTD REVEALS DYSREGULATION OF CRITICAL SIGNALING PATHWAYS

Briana Ondatje, Lauren Gittings, Kim Preller, Lynette Bustos, Jennifer Levy, Eric Alsop, Ritin Sharma, Melissa Martinez, Krystine Mansfield, Nate Hansen, Bessie Meechoovet, Robert Culibrk, Ignazio Piras, Matthew Huntelman, Patrick Pirrotte, Kendall Van Keuren- Jensen, Rita Sattler

A NOVEL MULTI-TARGET COMBINATION THERAPY FOR C9ORF72-RELATED AMYOTROPHIC LATERAL SCLEROSIS

Marco Cattaneo, Flaminia Fruzzetti, Eleonora Giagnorio, Giorgia Farinazzo, Claudia Malacarne, Silvia Bonanno, Eleonora Dalla Bella, Elia Di Schiavi, Nina Bono, Gabriele Candiani, Giuseppe Lauria, Stefania Marcuzzo

INVESTIGATING TRIPARTITE SYNAPSE PATHOLOGY IN ALS UTILIZING A HIPSC-DERIVED ORGANOID MODEL

Ahmad Jibai, Matthew Broadhead, Neela Murti, Laura Kibedi Makfalvi Varga, Channa Jakobs, Astrid Van der Geest, Kathryn Bowles, Jeroen Pasterkamp, Gareth Miles

ALPHA-TUBULIN ACETYLATION AS CRUCIAL REGULATOR OF CYTOSKELETAL FUNCTIONS IN MOTOR NEURONS

Jozefien Goethals, Adrià Sicart, Philip Van Damme, Ludo Van Den Bosch

CREB3R119G DRIVES NEURONAL RESILIENCE IN AMYOTROPHIC LATERAL SCLEROSIS

Nathan Burt-Oberecken, Stéphane Dieterlé, Luc Dupuis, Raphaelle Cassel, Salim Megat

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.